[
  {
    "ts": null,
    "headline": "Bristol Myers Squibb (BMY) Surpasses Market Returns: Some Facts Worth Knowing",
    "summary": "In the closing of the recent trading day, Bristol Myers Squibb (BMY) stood at $47.66, denoting a +1.32% move from the preceding trading day.",
    "url": "https://finnhub.io/api/news?id=e321d66c6175f92210275bc8722d8f87eab4e689a05e24f9ebd4b4ff7a209fe1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752097505,
      "headline": "Bristol Myers Squibb (BMY) Surpasses Market Returns: Some Facts Worth Knowing",
      "id": 135845486,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "In the closing of the recent trading day, Bristol Myers Squibb (BMY) stood at $47.66, denoting a +1.32% move from the preceding trading day.",
      "url": "https://finnhub.io/api/news?id=e321d66c6175f92210275bc8722d8f87eab4e689a05e24f9ebd4b4ff7a209fe1"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day",
    "summary": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=0a69f2b5d2ba63ce3f2b33f6092879767bce9c71ba6f678fb4dd089567f5d0ca",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752079200,
      "headline": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day",
      "id": 135861840,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=0a69f2b5d2ba63ce3f2b33f6092879767bce9c71ba6f678fb4dd089567f5d0ca"
    }
  },
  {
    "ts": null,
    "headline": "Recent Agreements Set To Bolster BioNTech SE (BNTX)’s Oncology Arm",
    "summary": "BioNTech SE (NASDAQ:BNTX) is one of the 13 Best German Stocks to Invest in Now. It is a clinical-stage biotechnology company focused on immunotherapies to treat cancer and other serious diseases. On June 2, the company announced that it had agreed with Bristol Myers Squibb for the global joint development and commercialization of BioNTech SE (NASDAQ:BNTX)’s […]",
    "url": "https://finnhub.io/api/news?id=917a120659ae01061764c32121344d094ba81b04af88c6c8190b78a5e1642b33",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752071445,
      "headline": "Recent Agreements Set To Bolster BioNTech SE (BNTX)’s Oncology Arm",
      "id": 135835972,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "BioNTech SE (NASDAQ:BNTX) is one of the 13 Best German Stocks to Invest in Now. It is a clinical-stage biotechnology company focused on immunotherapies to treat cancer and other serious diseases. On June 2, the company announced that it had agreed with Bristol Myers Squibb for the global joint development and commercialization of BioNTech SE (NASDAQ:BNTX)’s […]",
      "url": "https://finnhub.io/api/news?id=917a120659ae01061764c32121344d094ba81b04af88c6c8190b78a5e1642b33"
    }
  },
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb Company (BMY) Announces New Clinical Trial for Breast Cancer Drug Iza-bren",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the 10 Best Cheap Stocks to Buy According to Billionaire Ray Dalio. Bridgewater Associates holds over $142 million worth of shares of BMY, which represents 0.66% of its portfolio. On June 25, 2025, Bristol-Myers Squibb Company (NYSE:BMY) announced a new update regarding its plans for breast cancer treatments. […]",
    "url": "https://finnhub.io/api/news?id=b4ac1d192688cd7d33b1acf8a8aa3f1ff1e43305d35fb86386b2f57a6e60e485",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752070418,
      "headline": "Bristol-Myers Squibb Company (BMY) Announces New Clinical Trial for Breast Cancer Drug Iza-bren",
      "id": 135836107,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the 10 Best Cheap Stocks to Buy According to Billionaire Ray Dalio. Bridgewater Associates holds over $142 million worth of shares of BMY, which represents 0.66% of its portfolio. On June 25, 2025, Bristol-Myers Squibb Company (NYSE:BMY) announced a new update regarding its plans for breast cancer treatments. […]",
      "url": "https://finnhub.io/api/news?id=b4ac1d192688cd7d33b1acf8a8aa3f1ff1e43305d35fb86386b2f57a6e60e485"
    }
  },
  {
    "ts": null,
    "headline": "Will Recent Label Expansions of Opdivo Help BMY Gain Momentum?",
    "summary": "BMY leans on Opdivo's solid growth and new approvals as generics pressure its other top drugs and shares remain under pressure.",
    "url": "https://finnhub.io/api/news?id=7156988e2ac9d6348b73629f02770593e63008405c02fd4ad3cb311de6cf08d3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752067200,
      "headline": "Will Recent Label Expansions of Opdivo Help BMY Gain Momentum?",
      "id": 135835864,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "BMY leans on Opdivo's solid growth and new approvals as generics pressure its other top drugs and shares remain under pressure.",
      "url": "https://finnhub.io/api/news?id=7156988e2ac9d6348b73629f02770593e63008405c02fd4ad3cb311de6cf08d3"
    }
  }
]